Sectoral Asset Management Inc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$120.7M
Q ending 2026-03-31
Prior quarter
$124.8M
Q ending 2025-12-31
Change
-3.2% QoQ · -6.0% YoY
Positions
77
reported holdings

Largest positions

All 77 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Evommune IncEVMNShares$13.5M589K
Contineum TherapeuticsCTNMShares$9.5M728K
Shoulder InnovationsSIShares$6.3M430K
Eli Lilly & CoLLYShares$5.8M6K
Johnson & JohnsonJNJShares$4.5M18K
Gilead Sciences IncGILDShares$4.1M27K
Unitedhealth Grp IncUNHShares$4.0M15K
Amgen IncAMGNShares$3.5M9K
Vertex PharmaVRTXShares$3.5M7K
Insmed IncINSMShares$3.4M20K
Argenx SeARGXShares$2.7M4K
Abbvie IncABBVShares$2.7M12K
Abbott LabsABTShares$2.6M26K
Merck & Co IncMRKShares$2.6M21K
Regeneron PharmctclsREGNShares$2.5M3K
Intuitive Surgic IncISRGShares$2.4M5K
Boston ScientificBSXShares$2.2M35K
Biontech SeBNTXShares$2.0M22K
Stryker CorpSYKShares$1.9M6K
Danaher CorpDHRShares$1.8M10K
Thermo Fisher ScientificTMOShares$1.7M4K
Dexcom IncDXCMShares$1.5M23K
Iqvia Holdings IncIQVShares$1.4M8K
Summit TherapeuticsSMMTShares$1.4M70K
Edwards LifesciencesEWShares$1.4M17K
Bristol Myers SquibbBMYShares$1.3M21K
United TherapeuticsUTHRShares$1.1M2K
Vera TherapeuticsVERAShares$1.1M26K
Arcus BiosciencesRCUSShares$1.0M45K
Roivant Sciences LtdShares$1.0M33K
Medtronic PlcShares$962K11K
Trevi TherapeuticsTRVIShares$939K74K
Cogent BiosciencesCOGTShares$902K22K
Mineralys TherapeuticsMLYSShares$895K32K
Alnylam PharmacuetclALNYShares$864K2K
Tarsus PharmaceuticalsTARSShares$852K11K
Rapport TherapeuticsRAPPShares$835K25K
Nektar TherapeuticsNKTRShares$821K11K
Syndax PharmaceuticsSNDXShares$787K32K
Ardelyx IncARDXShares$781K122K
Pfizer IncPFEShares$772K28K
Boundless BioBOLDShares$746K679K
Ascendis Pharma A SShares$728K3K
Arrivent BiopharmaAVBPShares$720K30K
Structure TherapeuticsGPCRShares$711K14K
Immatics NvShares$693K67K
Bridgebio PharmaBBIOShares$687K8K
Ars PharmaceuticalsSPRYShares$677K79K
Beone Medicines LtdONCShares$631K2K
Tectonic TherapeuticTECXShares$628K19K
Ionis PharmaceuticalIONSShares$617K7K
Biomarin PharmacBMRNShares$607K9K
Kura Oncology IncKURAShares$606K71K
Privia Health GroupPRVAShares$558K27K
Cytokinetics IncCYTKShares$545K7K
Ptc Therapeutics IncPTCTShares$515K7K
Uniqure N.V.Shares$499K29K
Agomab TherapeuticsAGMBShares$477K44K
Alignment HealthALHCShares$474K27K
Hinge Health IncHNGEShares$472K12K
Radnet IncRDNTShares$447K8K
Royalty Pharma PlcShares$394K7K
Biogen IncBIIBShares$386K2K
Inspire Med Sys IncINSPShares$373K7K
Jazz Pharma PlcShares$371K2K
Neurocrine BiosciencesNBIXShares$344K2K
Oric PharmaceuticalsORICShares$333K24K
Omada Health IncOMDAShares$322K26K
Abivax SaABVXShares$298K2K
Illumina IncILMNShares$296K2K
Axsome TherapeuticAXSMShares$290K2K
Incyte CorporationINCYShares$254K2K
Moderna IncMRNAShares$248K4K
Medpace HoldingsMEDPShares$228K430
Guardant Health IncGHShares$206K2K
Revolution MedicinesRVMDShares$202K2K
Palisade Bio IncPALIShares$172K88K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.